Gene Expression Profiling of Peripheral Blood in Patients with Abdominal Aortic Aneurysm

European Journal of Vascular and Endovascular Surgery

Volumn 38, Issue 1, 2009, Pages 104-112

  Giusti, B ^a   Rossi, L ^a   Lapini, I ^a   Magi, A ^a   Pratesi, G ^b   Lavitrano, M ^c   Biasi, G M ^c   Pulli, R ^a   Pratesi, C ^a   Abbate, R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Abdominal aortic aneurysm; Erythrocyte genes; Gene expression profile; LRP5

Indexed keywords

ACYLGLYCEROL LIPASE; HEMOGLOBIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; RNA;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BLOOD; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; OXYGEN TRANSPORT; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE;

AGED; AGED, 80 AND OVER; AORTIC ANEURYSM, ABDOMINAL; DNA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LDL-RECEPTOR RELATED PROTEINS; LIPOPROTEIN(A); MALE; MIDDLE AGED; MONOACYLGLYCEROL LIPASES; POLYMERASE CHAIN REACTION; PROGNOSIS;

EID: 67349253521     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2009.01.020     Document Type: Article

References (30)

1. Cornuz J., Sidoti Pinto C., Tevaearai H., and Egger M. Risk factors for asymptomatic abdominal aortic aneurysm: systematic review and meta-analysis of population-based screening studies. Eur J Public Health 14 (2004) 343-349
2. Lederle F.A., Johnson G.R., Wilson S.E., Ballard D.J., Jordan Jr. W.D., Blebea J., et al., Veterans Affairs Cooperative Study #417 Investigators. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 287 (2002) 2968-2972
3. Thompson M.M. Infrarenal abdominal aortic aneurysms. Curr Treat Options Cardiovasc Med 5 (2003) 137-146
4. Blanchard J.F., Armenian H.K., and Friesen P.P. Risk factors for abdominal aortic aneurysm: results of a case-control study. Am J Epidemiol 151 (2000) 575-583
5. Lindblad B., Borner G., and Gottsater A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur J Vasc Endovasc Surg 30 (2005) 346-352
6. Wanhainen A., Bergqvist D., Boman K., Nilsson T.K., Rutegard J., and Bjorck M. Risk factors associated with abdominal aortic aneurysm: a population-based study with historical and current data. J Vasc Surg 41 (2005) 390-396
7. Sandford R.M., Bown M.J., London N.J., and Sayers R.D. The genetic basis of abdominal aortic aneurysms: a review. Eur J Vasc Endovasc Surg 33 (2007) 381-390
8. Thompson R.W., Absi T., and Tung W.S. Gene expression profiling of abdominal aortic aneurysms. J Vasc Surg 35 (2002) 403-404
9. Armstrong P.J., Johanning J.M., Calton Jr. W.C., Delatore J.R., Franklin D.P., Han D.C., et al. Differential gene expression in human abdominal aorta: aneurysmal versus occlusive disease. J Vasc Surg 35 (2002) 346-355
10. Absi T.S., Sundt III T.M., Tung W.S., Moon M., Lee J.K., Damiano Jr. R.R., et al. Altered patterns of gene expression distinguishing ascending aortic aneurysms from abdominal aortic aneurysms: complementary DNA expression profiling in the molecular characterization of aortic disease. J Thorac Cardiovasc Surg 126 (2003) 344-357
11. Lenk G.M., Tromp G., Weinsheimer S., Gatalica Z., Berguer R., and Kuivaniemi H. Whole genome expression profiling reveals a significant role for immune function in human abdominal aortic aneurysms. BMC Genomics 16 (2007) 237
12. Liew C.C., Ma J., Tang H.C., Zheng R., and Dempsey A.A. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 147 (2006) 126-132
13. Ardigo D., Gaillard C.A., and Braam B. Application of leukocyte transcriptomes to assess systemic consequences of risk factors for cardiovascular disease. Clin Chem Lab Med 45 (2007) 1109-1120
14. Barnett H.J., Meldrum H.E., Eliasziw M., and North American Symptomatic Carotid Evaluation Trial (NASCET) Collaborators. The appropriate use of carotid endarterectomy. CMAJ 166 (2002) 1169-1179
15. Sofi F., Marcucci R., Giusti B., Pratesi G., Lari B., Sestini I., et al. High levels of homocysteine, lipoprotein (a) and plasminogen activator inhibitor-1 are present in patients with abdominal aortic aneurysm. Thromb Haemost 94 (2005) 1094-1098
16. Giusti B., Serratì S., Margheri F., Papucci L., Rossi L., Poggi F., et al. The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis. Arthritis Rheum 52 (2005) 3618-3628
17. Giusti B., Fibbi G., Margheri F., Serratì S., Rossi L., Poggi F., et al. A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients. Arthritis Res Ther 8 (2006) R115
18. Yang Y.H., Dudoit S., Luu P., Lin D.M., Peng V., Ngai J., et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 30 (2002) e15
19. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarray applied to the ionizing radiation response. Proc Natl Acad Sci U S A 98 (2001) 5116-5121
20. Camon E., Magrane M., Barrell D., Lee V., Dimmer E., Maslen J., et al. The Gene Ontology Annotation (GOA) Database: sharing knowledge in Uniprot with Gene Ontology. Nucleic Acids Res 32 (2004) D262-266
21. Camon E., Barrell D., Lee V., Dimmer E., and Apweiler R. The Gene Ontology Annotation (GOA) Database - an integrated resource of GO annotations to the UniProt Knowledgebase. In Silico Biol 4 (2004) 5-6
22. Jones G.T., van Rij A.M., Cole J., Williams M.J., Bateman E.H., Marcovina S.M., et al. Plasma lipoprotein (a) indicates risk for 4 distinct forms of vascular disease. Clin Chem 53 (2007) 679-685
23. Little R.D., Recker R.R., and Johnson M.L. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 347 (2002) 943-944
24. Balemans W., and Van Hul W. The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes. Endocrinology 148 (2007) 2622-2629
25. Fujino T., Asaba H., Kang M.J., Ikeda Y., Sone H., Takada S., et al. Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci U S A 100 (2003) 229-234
26. Magoori K., Kang M.J., Ito M.R., Kakuuchi H., Ioka R.X., Kamataki A., et al. Severe hypercholesterolemia, impaired fat tolerance, and advanced atherosclerosis in mice lacking both low density lipoprotein receptor-related protein 5 and apolipoprotein E. J Biol Chem 278 (2003) 11331-11336
27. Sofi F., Marcucci R., Abbate R., Gensini G.F., and Prisco D. Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis. Am J Med 120 (2007) 728-733
28. Mallika V., Goswami B., and Rajappa M. Atherosclerosis pathophysiology and the role of novel risk factors: a clinicobiochemical perspective. Angiology 58 (2007) 513-522
29. Hofer T., Wenger R.H., Kramer M.F., Ferreira G.C., and Gassmann M. Hypoxic up-regulation of erythroid 5-aminolevulinate synthase. Blood 101 (2003) 348-350
30. Mohr S., and Liew C.C. The peripheral-blood transcriptome: new insights into disease and risk assessment. Trends Mol Med 13 (2007) 422-432